News

Gladstone in the News August 8, 2025

Lab-Grown Salmon Introduced by Bay Area-Based Seafood Company

ABC7 News—Gladstone alumnus Arye Elfenbein and his business partner, Justin Kolbeck, founded Wildtype to create cell-cultured seafood. Their company uses the same technology—known as induced pluripotent stem cells—that Elfenbein learned while working in the lab of Deepak Srivastava at Gladstone.

Gladstone Experts Srivastava Lab

Article August 6, 2025

How Do Vaccines Work?

An in-depth explainer about different types of vaccines and what happens in the body after vaccination.

Gladstone Experts COVID-19 Deep Dive

Gladstone in the News August 1, 2025

Jennifer Doudna Is Named 2026 Priestley Medalist

Chemical & Engineering News—Gladstone Investigator Jennifer Doudna is receiving the highest honor given by the American Chemical Society for discoveries on ribozyme function and CRISPR gene editing, and for her international science leadership.

Awards Gladstone Experts Doudna Lab

Video July 30, 2025

Our Research Is Explicitly Focused on Solving Disease | The Gladstone Difference

Gladstone unites more than 600 biologists, chemists, engineers, and data scientists, combining diverse expertise to uncover how the human body functions—and what drives disease.

Communications Gladstone Experts Institutional News

Gladstone in the News July 28, 2025

Gladstone Institutes Develops AI-Powered Thinking Microscope

ABC7 News—Steve Finkbeiner, director of the Center for Systems and Therapeutics at Gladstone, describes the revolutionary thinking microscope that his team developed to help identify better treatments for diseases like Alzheimer’s, Parkinson’s, and ALS.

Gladstone Experts ALS Alzheimer’s Disease Parkinson’s Disease Center for Systems and Therapeutics Finkbeiner Lab

Article July 28, 2025

Blood Vessels and Immune Cells Drive Risk for Alzheimer’s and Stroke

Gladstone scientists show that known genetic risk factors for neurological diseases act in the brain’s blood vessels and immune cells, revealing new targets for therapies.

News Release Research (Publication) Alzheimer’s Disease Neurological Disease Corces Lab Pollard Lab Yang Lab

Article July 22, 2025

Pregnancy, Lactation Shape Immune Response to COVID-19 Vaccine and Infection

Study finds strong immune defenses in pregnant and lactating women, with key benefits that could guide future vaccine design.

News Release Research (Publication) COVID-19 Infectious Disease Roan Lab

Gladstone in the News July 21, 2025

Two Cancer Drugs Show Surprising Promise in Treating Alzheimer’s

Discover Magazine—With so few Alzheimer’s drugs available, repurposing medications approved for other conditions could be the key to tackling this complex disease. In fact, Gladstone Investigator Yadong Huang and his colleagues at UCSF discovered that a combination of two cancer drugs could reduce brain degeneration and restore memory, pointing toward a potent treatment path never considered before.

Gladstone Experts Alzheimer’s Disease Huang Lab

Gladstone in the News July 21, 2025

Could Cancer Drugs Be the Future of Alzheimer’s Treatment?

NBC News—Gladstone Investigator Yadong Huang comments on a new study he helped lead, in which two cancer drugs showed signs of slowing or reversing symptoms of Alzheimer’s disease.

Gladstone Experts Alzheimer’s Disease Huang Lab

Article July 21, 2025

Inside the Brain: Tackling Neurological Disease at Its Roots

For World Brain Day, discover some of Gladstone’s latest breakthroughs in neurological research.

Gladstone Experts Research (Publication) Alzheimer’s Disease COVID-19 Parkinson’s Disease Neurological Disease Akassoglou Lab Corces Lab Huang Lab Mucke Lab

Article July 21, 2025

Combination of Two Cancer Drugs May Work Against Alzheimer’s

A new study has identified FDA-approved cancer drugs that reverse the gene expression signatures associated with Alzheimer’s.

News Release Research (Publication) Alzheimer’s Disease Neurological Disease Huang Lab

Article July 16, 2025

Remembering Bill Rutter, a Biotech Visionary and Champion of Gladstone

William J. Rutter, PhD, was a pioneering force in biomedicine whose vision shaped San Francisco’s Mission Bay neighborhood into a hub for innovation and discovery.

History Profile

Video July 9, 2025

Our San Francisco Location | The Gladstone Difference

Learn how Gladstone's location fosters enriching collaborations and partnerships.

Business Development Institutional News

Gladstone in the News June 23, 2025

5 Ways AI is Changing the Landscape of Cancer Research and Immunotherapy

Cancer Research Institute—Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, helps explain how AI will transform the future of cancer treatment and how scientists are shaping the next wave of progress in cancer immunotherapy.

Gladstone Experts Cancer Genomic Immunology Marson Lab

Gladstone in the News June 20, 2025

The New Luxury Medical Tourism Trend? $60K Stem-Cell Injections

The San Francisco Standard—Gladstone President Deepak Srivastava discusses the promise of true, scientifically proven stem-cell treatments—but shares concerns about international clinics that market stem-cell therapies without any evidence.

Gladstone Experts Srivastava Lab Stem Cells/iPSCs